Pacific countries will access future COVID-19 vaccine through funding mechanism

Pacific island countries will be able to access a future COVID-19 vaccine through a new funding mechanism announced by Gavi, The Vaccine Alliance, at the Global Vaccine Summit last week.

Fiji, Kiribati, Federated States of Micronesia, Papua New Guinea, Republic of the Marshall Islands, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu are all eligible for financing to access a COVID-19 vaccine when developed.

This follows Australia’s pledge of A$300 million for Gavi to continue its vital work in providing access to vaccines for countries across the Indo-Pacific.

“Our support to Gavi will also ensure our Fijian vuvale are not priced out of accessing a future COVID-19 vaccine in what will no doubt be a competitive global market,” said Australian High Commissioner to Fiji John Feakes.

Gavi is a public-private partnership that provides access to vaccines for low-income countries and will invest FJD1.8 billion from 2021 to provide access to a range of vaccines for 140 million children in the Indo-Pacific region over the next five years.